SCHEMBL6349263

SCHEMBL6349263

CN(c1ccc(Cl)cc1)S(=O)(=O)c1cc(C(=O)Nc2ccc(Br)cc2C(=O)O)ccc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT3A Q9Y6K1 1/20 0.48
AKR1C2 P52895 3/20 0.48
AKR1C1 Q04828 3/20 0.48
AKR1C4 P17516 1/20 0.48
AKR1C3 P42330 1/20 0.48
METAP2 P50579 1/20 0.47
SERPINE1 P05121 1/20 0.47
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
SIRT2 Q8IXJ6 2/20 0.45
PRSS12 P56730 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
SLC10A6 Q3KNW5 1/20 0.45
RPA1 P27694 2/20 0.44
KCNK2 O95069 1/20 0.44
KCNK10 P57789 1/20 0.44
GRIK1 P39086 1/20 0.44
ACLY P53396 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349380 0.92 RPA1 (0.51) DNMT3AAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6347700 0.90 MEN1 (0.53) DNMT3AAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6351360 0.88 METAP2 (0.55) DNMT3AAKR1C2AKR1C1METAP2SERPINE1
SCHEMBL6353746 0.85 SIRT2 (0.61) AKR1C2AKR1C1AKR1C4AKR1C3SIRT2
SCHEMBL6351777 0.85 ALB (0.51) DNMT3AAKR1C2AKR1C1SERPINE1MEN1
SCHEMBL6347687 0.84 METAP2 (0.50) DNMT3AAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6356961 0.84 METAP2 (0.53) METAP2SIRT2MEN1ALDH1A1KMT2A
SCHEMBL7063908 0.84 METAP2 (0.50) DNMT3AAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6351890 0.83 METAP2 (0.46) AKR1C2AKR1C1AKR1C4AKR1C3METAP2
SCHEMBL6819031 0.83 METAP2 (0.46) DNMT3AAKR1C2AKR1C1AKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 DNMT3A 1184/4885AKR1C2 3012/4885AKR1C1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.